These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26747454)

  • 1. Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models.
    Srinivas NR; Syed M
    Drugs R D; 2016 Mar; 16(1):69-79. PubMed ID: 26747454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the Prediction of Area Under the Curve for a Protease Inhibitor Using Trough Versus Peak Concentration: Assessment Using Published Pharmacokinetic Data for Indinavir.
    Srinivas NR
    Am J Ther; 2017; 24(4):e405-e418. PubMed ID: 26291590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for the Prediction of Steady-State Exposure of Digoxin to Determine Drug-Drug Interaction Potential of Digoxin With Other Drugs in Digitalization Therapy.
    Srinivas NR
    Am J Ther; 2019; 26(1):e54-e65. PubMed ID: 26808357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application.
    Srinivas NR; Syed M
    J Pain Palliat Care Pharmacother; 2016; 30(1):13-24. PubMed ID: 26865407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.
    Srinivas NR
    Biopharm Drug Dispos; 2015 Dec; 36(9):575-86. PubMed ID: 26224332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models.
    Bhamidipati RK; Syed M; Mullangi R; Srinivas N
    Xenobiotica; 2018 Feb; 48(2):148-156. PubMed ID: 28290233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited Sampling Strategy for the Prediction of Area Under the Curve (AUC) of Statins: Reliability of a Single Time Point for AUC Prediction for Pravastatin and Simvastatin.
    Srinivas NR
    Drug Res (Stuttg); 2016 Feb; 66(2):82-93. PubMed ID: 26011815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable Linezolid Exposure in Intensive Care Unit Patients-Possible Role of Drug-Drug Interactions.
    Töpper C; Steinbach CL; Dorn C; Kratzer A; Wicha SG; Schleibinger M; Liebchen U; Kees F; Salzberger B; Kees MG
    Ther Drug Monit; 2016 Oct; 38(5):573-8. PubMed ID: 27631464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
    Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis.
    Kamp J; Bolhuis MS; Tiberi S; Akkerman OW; Centis R; de Lange WC; Kosterink JG; van der Werf TS; Migliori GB; Alffenaar JC
    Int J Antimicrob Agents; 2017 Jun; 49(6):688-694. PubMed ID: 28389352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites.
    Srinivas NR
    Drug Dev Ind Pharm; 2016; 42(6):945-57. PubMed ID: 26467209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Common mdr1 Gene Polymorphism is Associated With Changes in Linezolid Clearance.
    Allegra S; Di Paolo A; Cusato J; Fatiguso G; Arrigoni E; Danesi R; Corcione S; DʼAvolio A
    Ther Drug Monit; 2018 Oct; 40(5):602-609. PubMed ID: 29979333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of micafungin area under the curve data by using peak concentration: applicability and utility in antifungal therapy.
    Srinivas NR
    Future Microbiol; 2016; 11(4):485-90. PubMed ID: 27070500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictions of the Pharmacokinetics in Burn Injury Patients using Regression Models - Case Study with Levofloxacin.
    Srinivas NR
    Drug Res (Stuttg); 2016 Oct; 66(10):555-560. PubMed ID: 27490937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Incorporation of the in vitro Data (IC50) and in vivo (Cmax) Data for the Prediction of Area Under the Curve (AUC) for Statins using Regression Models Developed for Either Pravastatin or Simvastatin.
    Srinivas NR
    Drug Res (Stuttg); 2016 Aug; 66(8):402-6. PubMed ID: 27144659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A limited sampling method for the estimation of flunarizine area under the curve (AUC) and maximum plasma concentration (Cmax).
    Mahmood I; Sahlroot JT
    Biopharm Drug Dispos; 1997 Mar; 18(2):117-26. PubMed ID: 9099448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
    Pea F; Cojutti PG; Baraldo M
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):303-308. PubMed ID: 28419737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
    Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH
    Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated calculation and reporting of vancomycin area under the concentration-time curve: a simplified single-trough concentration-based equation approach.
    Kim H-K; Jeong T-D; Ji M; Kim S; Lee W; Chun S
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0069924. PubMed ID: 39194211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.